StockData
Jaguar Health, Inc. logo

Jaguar Health, Inc. (JAGX) stock

JAGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$0.38−0.01 (-2.59%)

Close on Nov 17, 2026Market cap $1.96MP/E –Yield –

Jaguar Health operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Jaguar Health's operating cash flow for the twelve months ending Jun 30, 2026 was -$6.69M. For fiscal 2025 it was -$23.69M. The highest annual figure on record is -$5.36M in fiscal 2014.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$23.69M–
FY2024Dec 31, 2024-$29.38M–
FY2023Dec 31, 2023-$33.24M–
FY2022Dec 31, 2022-$33.10M–
FY2021Dec 31, 2021-$34.97M–
FY2020Dec 31, 2020-$15.28M–
FY2019Dec 31, 2019-$20.46M–
FY2018Dec 31, 2018-$22.73M–
FY2017Dec 31, 2017-$9.82M–
FY2016Dec 31, 2016-$14.41M–
FY2015Dec 31, 2015-$14.32M–
FY2014Dec 31, 2014-$5.36M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$5.34M–
Q1 FY2026Mar 31, 2026$8.83M–
Q4 FY2025Dec 31, 2025-$5.49M–
Q3 FY2025Sep 30, 2025-$4.69M–
Q2 FY2025Jun 30, 2025-$6.20M–
Q1 FY2025Mar 31, 2025-$7.31M–
Q4 FY2024Dec 31, 2024-$7.83M–
Q3 FY2024Sep 30, 2024-$6.34M–
Q2 FY2024Jun 30, 2024-$8.17M–
Q1 FY2024Mar 31, 2024-$7.05M–
Q4 FY2023Dec 31, 2023-$7.45M–
Q3 FY2023Sep 30, 2023-$6.79M–
Q2 FY2023Jun 30, 2023-$9.06M–
Q1 FY2023Mar 31, 2023-$9.95M–
Q4 FY2022Dec 31, 2022-$6.42M–
Q3 FY2022Sep 30, 2022-$8.53M–
Q2 FY2022Jun 30, 2022-$10.46M–
Q1 FY2022Mar 31, 2022-$7.70M–
Q4 FY2021Dec 31, 2021-$8.92M–
Q3 FY2021Sep 30, 2021-$9.43M–
Q2 FY2021Jun 30, 2021-$9.91M–
Q1 FY2021Mar 31, 2021-$6.71M–
Q4 FY2020Dec 31, 2020-$4.06M–
Q3 FY2020Sep 30, 2020-$2.92M–
Q2 FY2020Jun 30, 2020-$4.00M–
Q1 FY2020Mar 31, 2020-$4.30M–
Q4 FY2019Dec 31, 2019-$3.14M–
Q3 FY2019Sep 30, 2019-$8.55M–
Q2 FY2019Jun 30, 2019-$5.31M–
Q1 FY2019Mar 31, 2019-$3.47M–
Q4 FY2018Dec 31, 2018-$4.90M–
Q3 FY2018Sep 30, 2018-$2.81M–
Q4 FY2017Dec 31, 2017-$5.33M–
Q3 FY2017Sep 30, 2017-$3.03M–
Q2 FY2017Jun 30, 2017-$1.18M–
Q1 FY2017Mar 31, 2017-$288.72K–
Q4 FY2016Dec 31, 2016-$2.73M–
Q3 FY2016Sep 30, 2016-$3.38M–
Q2 FY2016Jun 30, 2016-$3.78M–

More Jaguar Health figures

See a number that looks wrong?